Brought to you by

Week ending January 12, 2015:

Recent Health Care M&A Deals






Foundation Medicine, Inc.

$780 million


Rights to OP0595


Biogen Idec

Covergence Pharmaceuticals

$200 million

Merck & Co.

Moderna Therapeutics collaboration

$100 million

Intrexon and Ziopharm Oncology

License to MD Anderson technologies

$100 million

Amarantus BioScience Holdings, Inc

DioGenix, Inc.

$8.9 million

Biotech’s Big Month
With the JP Morgan Healthcare Summit attracting so many dealmakers to San Francisco last week, it isn’t surprising that biotech deals dominated the headlines. At least 10 deals were announced since January 11, the day before the conference began, with $1.9 billion in disclosed prices. Biogen Idec (NASDAQ: BIIB) made a splash with its $200 million deal for Convergence Pharmaceuticals, but was quickly upstaged by Roche’s (SIX: RO) $780 million investment in Foundation Medicine, Inc., a molecular information company backed by Third Rock Ventures, Kleiner Perkins Caufield & Byers and Google Ventures. Nice exit, all.

Biggest Health Care M&A Spenders in 2014
Biopharmaceutical companies dominated the list of biggest spenders in 2014, as pharmaceutical companies slimmed down in some areas and bulked up in others. Medical device maker Medtronic (NYSE: MDT) was the only buyer to break into the club, thanks mainly to its $43 billion deal for Covidien plc (NYSE: COV). Actavis plc (NYSE: ACT) made news last January with its $25 billion purchase of Forest Labs (NYSE: FRX), but that only got the ball rolling, as they say.

Top Acquirers in 2014, by Total Spending




Actavis plc


$91.8 billion

Medtronic Inc.


$43.7 billion

Merck & Co.


$30.5 billion

Novartis Corp.


$16.2 billion

Bayer AG


$14.3 billion



$9.1 billion

Source: The Health Care M&A Information Source, January 2015

Hospital Deals Warming Up in 2015
Okay, five deals doesn’t sound like much after we count 15 biotech deals in the first two weeks of January. But the five transactions we’ve logged so far have that sector on track to match last January’s total of eight deals. On the books so far: TriHealth buying McCullough-Hyde Memorial Hospital for $17 million; Conemaugh Health System acquiring Nason Hospital for $12 million; Ascension Health Michigan taking on Crittenton Hospital Medical Center; Stony Brook University Hospital added Southampton Hospital; and over in India, Apollo Health & Lifestyle Ltd. paying an undisclosed amount for Nova Specialty Hospitals. This could be a busy year.

Biotech VC Investing Sets New Record in 2014
A report from PricewaterhouseCoopers confirms what we already know. Venture capital investment poured into biotech companies last year (they combine biotechnology and medical devices). According to PwC, VC financing grew 29% in 2014, to $6 billion, while the number of deals actually dropped, down 4% to 470. That still tops the previous record set in 2008 with $8.6 billion invested in 789 deals. And all those startups and development-stage companies are hoping for even bigger money in 2015, which could mean M&A growth. We’ll keep an eye out. ………….Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

Around the Web in Health Care M&A…Click here to see more

Webcast Calendar…Click here to see more

Upcoming Investor Conferences…Click here to see more

Previous Issues of Health Care Deal News…Click here to see more